Cyclacel Pharmaceuticals, Inc.
CYCC
$0.23
-$0.0152-6.20%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -50.30% | 114.44% | -17.17% | -43.17% | -41.52% |
| Total Receivables | 28.13% | -27.48% | -54.21% | 16.07% | 29.39% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -13.63% | 31.61% | -58.46% | 14.45% | -30.17% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.00% | -17.81% | 7.04% | -82.51% | -10.80% |
| Total Current Assets | -36.25% | 59.40% | -35.05% | -33.02% | -27.34% |
|
|
|||||
| Total Current Assets | -36.25% | 59.40% | -35.05% | -33.02% | -27.34% |
| Net Property, Plant & Equipment | -21.43% | -18.60% | -15.69% | -18.40% | -15.54% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -66.80% | -1.19% | 0.00% | 25.90% |
| Total Assets | -34.30% | 32.85% | -29.98% | -29.54% | -23.99% |
|
|
|||||
| Total Accounts Payable | -12.97% | -8.83% | 46.77% | 125.53% | -27.57% |
| Total Accrued Expenses | -7.66% | -28.17% | -32.66% | -31.88% | 43.24% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -15.95% | 33.45% | -22.11% | 6.74% | 52.14% |
| Total Other Current Liabilities | -15.95% | 33.45% | -22.11% | 6.74% | 52.14% |
| Total Current Liabilities | -11.62% | -13.94% | 2.32% | 0.16% | 20.78% |
|
|
|||||
| Total Current Liabilities | -11.62% | -13.94% | 2.32% | 0.16% | 20.78% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -76.19% | -43.24% | -28.85% | -21.21% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -11.68% | -14.10% | 2.11% | -0.02% | -27.47% |
|
|
|||||
| Common Stock & APIC | 0.02% | 1.51% | 0.03% | 0.31% | 1.14% |
| Retained Earnings | -0.45% | -0.76% | -0.69% | -1.25% | -1.34% |
| Treasury Stock & Other | -12.90% | -1.89% | 1.10% | 22.26% | -6.47% |
| Total Common Equity | -197.10% | 145.29% | -463.43% | -85.87% | -16.34% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -197.10% | 145.29% | -463.43% | -85.87% | -16.34% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -197.10% | 145.29% | -463.43% | -85.87% | -16.34% |
|
|
|||||
